Ambulatory Cancer Care Electronic Symptom Self-Reporting for Surgical Patients
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Locations
-
-
New York
-
New York, New York, United States, 10065
- Memorial Sloan Kettering Cancer Center
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- All patients >18 years of age who are scheduled for ambulatory cancer surgery at JRSC and their caregivers will be eligible for study participation.
Exclusion Criteria:
- Inability to speak English
- Inability to access a computer, tablet, or mobile phone
- For patients: not interested in/unable to sign up for the MyMSK Patient Portal
- For caregivers: Unable to provide an email address
- Cognitive impairment that prohibits informed consent or understanding of the study protocol
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Team Monitoring
Team Monitoring is the current standard of care for patients at Josie Robertson Surgery Center (JRSC).
|
In this cohort, the electronic system will provide advanced informatics support for push notifications to the care team based on the severity of the symptoms reported.
This platform promotes early detection and intervention.
The care team is alerted when patients experience symptoms out of the expected range or if symptoms are worsening.
Nurses receive secure message notifications and will contact the patient by phone depending on symptom severity.
If a patient responds with a moderate-severe answer, the office team gets an alert and calls the patient during business hours.
|
|
Enhanced Feedback
The electronic system will provide tailored normative data visualizations that offer context and education to patients regarding expected symptom severity.
|
In this cohort, the electronic system will provide tailored normative data visualizations that offer context and education to patients regarding expected symptom severity.
The information provided to patients in the Enhanced Feedback group will be procedure specific and based on continuously updated PRO-CTCAE data from previous patients.
Patients are thus able to see their own recovery trajectory relative to that of patients who have undergone the same procedure.
Care is patient activated in that patients will use the information about expected symptoms to decide whether they should call the care team (e.g., if they are experiencing symptoms that are more severe or more prolonged than expected).
If a patient reports severe symptoms, they are instructed to immediately contact their physician's office or seek medical attention.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Rates of UCC Visits and Readmissions Between the Team Monitoring and Enhanced Feedback Cohorts up to 30 Days Post-operatively
Time Frame: 30 days
|
To compare the effectiveness of Team Monitoring and Enhanced Feedback with regard to urgent care, emergency department visits, and readmissions up to 30 days post-operatively.
|
30 days
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Difference in Total Number of Nursing Follow-up Calls Between Team Monitoring and Enhanced Feedback Cohorts up to 30 Days Post-Operatively
Time Frame: 30 days post-operatively
|
To evaluate the difference in nursing phone calls between each study arm up to 30 days post-operatively.
|
30 days post-operatively
|
|
Differences in Total Number of Unplanned Clinic Visits Between Team Monitoring and Enhanced Feedback Cohorts Up to 30 Days Post-Operatively
Time Frame: 30 days post-operatively
|
To evaluate the difference in unplanned clinic visits and phone referrals to clinic between each study arm up to 30 days post-operatively.
|
30 days post-operatively
|
|
Differences in Total Number of Pain Management Referrals Between Team Monitoring and Enhanced Feedback Cohorts Up to 30 Days Post-Operatively
Time Frame: 30 days post-operatively
|
To evaluate the difference in pain management referrals between each study arm up to 30 days post-operatively.
|
30 days post-operatively
|
|
Differences in Adverse Events Between Team Monitoring and Enhanced Feedback Cohorts Up to 30 Days Post-Operatively
Time Frame: 30 days post-operatively
|
To evaluate the difference in adverse events between each study arm up to 30 days post-operatively.
|
30 days post-operatively
|
|
Interaction in Participants Anxiety Measured by 3 Items on the Patient Reported Outcome Common Terminology Criteria for Adverse Events Survey (PRO-CTCAE)
Time Frame: 10 days post-operatively
|
This analysis utilized 3 anxiety items from the PRO-CTCAE survey.
The responses were defined on a scale of 0-4 with higher scores representing stronger agreement with the item (higher anxiety).
The 3 items were summed to generate an overall score ranging from 0-12.
139 patients responded to only some of the 3 items and were counted as a missing value for the overall sum score.
As the surveys were repeated daily, longitudinal mixed effects regression was used to test the association between the anxiety sum score and randomization arm after adjusting for time, randomization strata, and an interaction between randomization arm and time with a random intercept for patient.
|
10 days post-operatively
|
|
Differences in Patient Engagement Between Cohorts at 14 Days Post-Operatively Utilizing the Patient Activation Measure (PAM) and Adjusting for Strata and Pre-Operative PAM Score
Time Frame: 14 days post-operatively
|
To evaluate the difference in patient engagement between each study arm at 14 days post-operatively adjusting for strata and preoperative PAM overall score.
The survey consists of 10 items with five response options: strongly disagree, disagree, undecided, agree and strongly agree defined on a scale of 1-5 with higher scores representing stronger agreement with the item.
The items in the PAM survey were combined to generate an overall mean score at each timepoint - a theoretical score of 0-100.
A higher score indicates stronger patient engagement.
If a patient is missing a response to an item(s), the overall score is considered missing for that patient/timepoint.
Participants who answered the survey were included in this analysis.
560 patients were analyzed in the Team Monitoring Arm and 541 were analyzed in the Enhanced Feedback Arm.
|
14 days post-operatively
|
|
Differences in Patient Engagement Between Team Monitoring and Enhanced Feedback Cohorts at 60 Days Post-Operatively Utilizing the Patient Activation Measure (PAM) and Adjusting for Strata and Pre-Operative PAM Score
Time Frame: 60 days post-operatively
|
To evaluate the difference in patient engagement between each study arm 60 days post-operatively adjusting for strata and preoperative PAM overall score.
The survey consists of 10 items with five response options: strongly disagree, disagree, undecided, agree and strongly agree defined on a scale of 1-5 with higher scores representing stronger agreement with the item.
The items in the PAM survey were combined to generate an overall mean score at each timepoint - a theoretical score of 0-100.
A higher score indicates stronger patient engagement.
If a patient is missing a response to an item(s), the overall score is considered missing for that patient/timepoint.
465 participants form the Team Monitoring Arm and 460 participants from the Enhanced Feedback arm were analyzed who answered the Patient Activation Measure at POD 60.
|
60 days post-operatively
|
|
Differences in Caregiver Burden Between Team Monitoring and Enhanced Feedback Cohorts Utilizing the Caregiver Reaction Assessment (CRA).
Time Frame: 14 days post-operatively
|
To evaluate the difference in caregiver burden between each study arm at two timepoints: 14 days post-operatively.
Scoring information for the CRA: The Caregiver Reaction Assessment involved 24 items given at 14 days and repeated at 60 days with the following potential responses: strongly disagree, disagree, undecided, agree, and strongly agree which we defined on a scale of 1-5 with higher scores representing stronger agreement with the item.
These items are combined into 5 subscales: health problems, financial problems, lack of family support, disrupted schedule, and self-esteem.
For each subscale, a total score was computed as the average of the subsequent item scores, with a range between 1 and 5.
A higher score represented a stronger agreement with the attribute.
|
14 days post-operatively
|
|
Differences in Caregiver Burden Between Team Monitoring and Enhanced Feedback Cohorts Utilizing the Caregiver Reaction Assessment (CRA).
Time Frame: 60 days post-operatively
|
To evaluate the difference in caregiver burden between each study arm at two timepoints: 60 days post-operatively.
Scoring information for the CRA: The Caregiver Reaction Assessment involved 24 items given at 14 days and repeated at 60 days with the following potential responses: strongly disagree, disagree, undecided, agree, and strongly agree which we defined on a scale of 1-5 with higher scores representing stronger agreement with the item.
These items are combined into 5 subscales: health problems, financial problems, lack of family support, disrupted schedule, and self-esteem.
For each subscale, a total score was computed as the average of the subsequent item scores, with a range between 1 and 5.
A higher score represented a stronger agreement with the attribute.
|
60 days post-operatively
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Robert Allen, MD, Memorial Sloan Kettering Cancer Center
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- 17-293
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Patient Reported Outcomes
-
NCT03435484CompletedPatient-reported Outcomes
-
NCT03536715CompletedPatient-Reported Outcomes (PRO)
-
NCT03201484UnknownParotidectomy, Patient-reported Outcomes
-
NCT07048041CompletedTotal Hip Replacement | Patient-Reported Outcomes
-
NCT03871920UnknownPatient Reported Outcomes
-
NCT05808907RecruitingPROM | Transcatheter Aortic Valve Implantation | Patient Reported Outcomes
-
NCT07121335RecruitingOligometastasis | ctDNA | Oligoprogression | Patient-Reported Outcomes (PRO) | Stereotactic Body Radiation Therapy (SBRT)
-
NCT04397627UnknownColorectal Surgery | Enhanced Recovery After Surgery | Patient Reported Outcomes
-
NCT06100978RecruitingRelatives | Patient Satisfaction | Intensive Care Unit | Status Epilepticus | Burden | Patient Reported Outcomes | Long Term Outcomes
-
NCT06928961Not yet recruitingHIV | Screening | Patient Portals | Patient-Reported Outcomes (PRO)
Clinical Trials on Team Monitoring
-
NCT05488795Active, not recruitingHypertension | High Blood Pressure
-
NCT02421874UnknownSerious Emotional Disturbance of Youth
-
NCT07024329Recruiting
-
NCT04829188CompletedPneumonia | Sepsis | Covid19 | Lower Resp Tract Infection
-
NCT00644644CompletedHypertension | Bradycardia | Tachycardia | Hypotension | Desaturation
-
NCT02540629Terminated
-
NCT04490291CompletedChronic Pain | Spine Disease
-
NCT02827188CompletedAttention-deficit Hyperactivity Disorder
-
NCT03502239CompletedADHD | ASD | CHD - Congenital Heart Disease